Patent ID: 6706270
Filing Date: 2004-03-16
Classification: A61K,C07K

Abstract:
An isolated, recombinant polypeptide comprising a member selected from the group consisting of(a) the amino acid sequence SEQ ID NO:2; (b) an immunogenic fragment of at least 15 contiguous amino acids of SEQ ID NO:2 wherein the immunogenic fragment is selected from one of the following fragments: 1-15; 2-16; 3-17; 4-18; 5-19; 6-20; 7-21; 8-22; 9-23; 22-36; 23-37; 24-38; 25-39; 26-40; 27-41; 28-42; 29-43; 30-44; 31-45; 193-207; 194-208; 195-209; 196-210; 197-211; 198-212; 199-213; 200-214; 201-215; 202-216; 203-217; 204-218; 205-219; 206-220; 207-221; 208-222; and 209-223; wherein the immunogenic fragment, when administered to a subject in a suitable composition which can include an adjuvant, or a suitable carrier coupled to the polypeptide, induces an antibody or T-cell mediated immune response that recognizes the polypeptide SEQ ID NO:2.